EQL Pharma AB (FRA:7JK) Total Stockholders Equity : €16.67 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Total Stockholders Equity?

EQL Pharma AB's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €16.67 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. EQL Pharma AB's Book Value per Share for the quarter that ended in Jun. 2024 was €0.57. The ratio of a company's debt over equity can be used to measure how leveraged this company is. EQL Pharma AB's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.81.

EQL Pharma AB Total Stockholders Equity Historical Data

The historical data trend for EQL Pharma AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Total Stockholders Equity Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

7.44

8.97

11.74

13.80

15.71

EQL Pharma AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															13.85	14.08	15.47	15.71	16.67

EQL Pharma AB (FRA:7JK) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

EQL Pharma AB's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(16.666	-	0)	/	29.0636
	=	0.57

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

EQL Pharma AB's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.966	+	1.471)	/	16.666
	=	0.81

EQL Pharma AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB Headlines

No Headlines